Pliant Therapeutics Inc (PLRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $42.97M
Last updated: Nov 17, 2026 at 4:06 PM ET
Pliant Therapeutics Inc (PLRX) Stock Chart
Pliant Therapeutics (PLRX) has a latest price of $0.66 on Nov 17, 2026, 60.5% below its 52-week high of $1.67. Its price fell 60.7% over the past 12 months. The month-end price fell 94.6% over the 5 years through Oct 2026, a compound annual decline of 44.2%.
Price Chart
From Jun 2020 to Oct 2026, its highest month-end close was $39.33 in Mar 2021 and its lowest $0.86 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PLRX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PLRX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 43.6%, and over 6 months it fell 42.6%. The month-end price fell 94.1% over the 3 years through Oct 2026, a compound annual decline of 61.2%.
| Period | Change |
|---|---|
| 1 month | -26.5% |
| 3 months | -43.6% |
| 6 months | -42.6% |
| 12 months | -60.7% |
| 12 months, with dividends | -60.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -94.1% | -61.2% |
| 5 years | -94.6% | -44.2% |
Price by Year
Its best calendar year was 2022, when the price rose 43.2%, and its weakest was 2025, when it fell 90.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.86 | -29.6% |
| 2025 | $1.22 | -90.7% |
| 2024 | $13.17 | -27.3% |
| 2023 | $18.11 | -6.3% |
| 2022 | $19.33 | +43.2% |
| 2021 | $13.50 | -40.6% |
Trading Range
The price is 30.9% below its 50-day average of $0.96 and 41.7% below its 200-day average of $1.13.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.66 | |
| 52-week high | $1.67 | -60.5% |
| 52-week low | $0.66 | 0.0% |
| 50-day average | $0.96 | -30.9% |
| 200-day average | $1.13 | -41.7% |
Price Risk
Over 3 years, its largest fall from a peak was 96.6%.
| Measure | Value |
|---|---|
| 1-year beta | 0.90 |
| Largest fall, 1 year | -60.0% |
| Largest fall, 3 years | -96.6% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PLRX
What is PLRX's 1-year price change?
Pliant Therapeutics's price fell 60.7% over the past 12 months. With dividends included, the 12-month total return was -60.7%.
What is PLRX's 5-year price change?
Pliant Therapeutics's month-end price fell 94.6% over the 5 years through Oct 2026, a compound annual decline of 44.2%. These figures leave out dividends.
What is PLRX's 52-week high and low?
Pliant Therapeutics's 52-week high is $1.67 and its 52-week low is $0.66. Its latest price of $0.66 on Nov 17, 2026 is 60.5% below the high.
What is PLRX's beta?
Pliant Therapeutics's 1-year beta against the S&P 500 is 0.90, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 60.0%.
Is the PLRX chart free?
Yes. Advanced Charting for PLRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PLRX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors